Mono‐ or biallelic inactivating, pathogenic variants in TSHR result in a spectrum of TSH resistance which, if complete (e.g., due to biallelic and nonfunctional TSHR alleles) results in severe gland hypoplasia and profound CH. This evidence concerns the gene TSHR and cyclic hematopoiesis.